ScholarWorks@Dongguk University: Lee, Nam Young

Detailed Information

Lee, Nam Young (이남영)

Graduate School (Department of Medicine)

Research Area

Tel 031-961-7233
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Schizophrenia:4||Electroconvulsive therapy.:3||schizophrenia:3||Auditory verbal hallucination:2||Autism spectrum disorder:2||Psychopathology:2||Beck Anxiety Inventory:2||Catatonia:2||Paliperidone ER:2||Insight:2||Schizophrenia.:2||정신병리:2||조현병:2||조현병.:2||Intellectual disabilities:2||Electroconvulsive therapy:2||Selfinjurious behavior:2||metabolic syndrome:2||Metabolic syndrome:2||Glucagonlike peptide receptors:1||Incidence:1||Intelligence:1||Leptin:1||Longacting injectable antipsychotics:1||MMI:1||Major depressive disorder:1||Mediator:1||Mental disorder:1||Mental disorders:1||Metabolic Syndrome:1||Mood disorder:1||Neurodevelopmental disorder:1||Nonremitter:1||Normalization:1||Obesity:1||Patient satisfaction survey.:1||Personality:1||Pharmacology:1||Phendimetrazine.:1||Phentermine:1||Psychiatric disorders:1||Psychiatric specialists:1||Randomized controlled trial:1||Resistin:1||Safety:1||Schizophrenia · Insight · Psychopathology · Negative symptom · SelfRating Scale.:1||Secondgeneration antipsychotics:1||Selfreporting:1||Student selection:1||Substanceinduced psychotic disorder:1||Substancerelated disorders:1||Survey of knowledge and attitudes.:1||Technologyenhanced assessment:1||Temperament:1||Tolerability:1||alanine aminotransferase:1||anxiety:1||bifactor model:1||bifactor 모형:1||clozapine:1||factor structure:1||indirectly standardized prevalence ratio:1||polymorphism:1||remission rate:1||risperidone longacting injectable:1||내약성:1||물질/약물치료로 유발된 정신병적 장애·물질 사용장애·Phendimetrazine·Phentermine.:1||병식:1||불안:1||안전성:1||언어성 환청:1||요인구조:1||장기지속형 주사제:1||지역사회정신보건센터:1||Adiponectin:1||효능:1||Adverse events.:1||Aminotransferase levels:1||Antipsychotic agents:1||Anxiety:1||Atypical antipsychotics:1||Benzodiazepine:1||Bipolar disorder:1||CLOCK gene:1||Clinician rating:1||Community mental health centers:1||Depression:1||Depression.:1||Developmental disorder:1||Dose escalation:1||Effectiveness:1||Elderly:1||Empathy:1||Escitalopram:1||

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE